CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CIBC Private Wealth Group, LLC | 122,649 | $230,580 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 15,994 | $30,069 | 0.00% |
| MORGAN STANLEY | 123,308 | $231,819 | 0.00% |
| COMERICA BANK | 258 | $485 | 0.00% |
| BlackRock Inc. | 726,764 | $1,366,317 | 0.00% |
| Bank of New York Mellon Corp | 51,621 | $97,047 | 0.00% |
| Citadel Advisors | 2,200 | $4,136 | 0.00% |
| Citadel Advisors | 2,100 | $3,948 | 0.00% |
| Citadel Advisors | 30,688 | $57,693 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 61,931 | $116,430 | 0.00% |
| HRT FINANCIAL LP | 10,256 | $19 | 0.00% |
| Tower Research Capital LLC (TRC) | 803 | $1,510 | 0.00% |
| Qube Research & Technologies Ltd | 1 | $2 | 0.00% |
| Your Advocates Ltd., LLP | 250 | $470 | 0.00% |
| SIMPLEX TRADING, LLC | 1,168 | $2 | 0.00% |
| JPMORGAN CHASE & CO | 372 | $699 | 0.00% |
| Park Place Capital Corp | 781 | $1,468 | 0.00% |
| Renaissance Technologies | 119,100 | $224 | 0.00% |
| BARCLAYS PLC | 5,577 | $10 | 0.00% |
| Creative Planning | 21,295 | $40,035 | 0.00% |
External links
This page lists CYTOSORBENTS CORP's shareholders in Q3 2023. To view CYTOSORBENTS CORP's shareholder history, click here.